Industry News

Bharat Biotech International Limited (BBIL) has entered into a licensing agreement with GSK plc to take over the development of altSonflex1‑2‑3, GSK’s promising Shigella vaccine candidate.

Novartis announced promising results from its Phase IIIB APPULSE-PNH study, evaluating the twice-daily oral monotherapy Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria

NVIDIA announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases. The work supports Novo Nordisk’s agreement with DCAI to use the Gefion sovereign AI supercomputer.

Pharmazz, Inc. a late-stage biopharmaceutical company developing innovative therapies for unmet medical needs in critical care and neurology, has announced a 25 million USD equity investment from Sun Pharmaceutical Industries Limited

Telix Pharmaceuticals Limited announces that its next-generation PSMA-PET imaging1 agent for prostate cancer, Gozellix (kit for the preparation of gallium-68 , is now commercially available nationally in the United States (U.S.).

Zydus Lifesciences has received the Establishment Inspection Report from the United States Food and Drug Administration for its Active Pharmaceutical Ingredient manufacturing facility located at Dabhasa, near Vadodara, Gujarat.

Zydus Lifesciences Ltd. announced its entry into the global biologics contract development and manufacturing organization

Ichnos Glenmark Innovation (IGI), a global, fully integrated clinical- stage biotechnology company focused on developing multispecificsTM in oncology, today presented promising full dose-escalation results from its Phase 1 TRIgnite-1 study of ISB 2001

Biocon Pharma Limited, has received approval for its Liraglutide drug product (6 mg/ml solution for injection in pre-filled pen and cartridge), from the Drugs Controller General of India, CDSCO (Central Drugs Standard Control Organisation).